Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Swedish stent maker Jomed plans market listing:

This article was originally published in Clinica

Executive Summary

Jomed, a Swedish manufacturer of cardiac minimally-invasive devices, plans a stock market listing by 2000 that could value the company at up to Euro800 million ($862 million). It is believed the Helsingborg-based group will list in Frankfurt rather than Stockholm. In 1998, the company's sales grew by 68% to Euro25.5 million, while profits almost tripled to Euro6.1 million. Jomed has expanded rapidly since its launch in the early 1990s, reflecting the corresponding growth in minimally-invasive surgery in the hospital sector.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT078309

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel